Does LORLATINIB Cause Muscular weakness? 43 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Muscular weakness have been filed in association with LORLATINIB (Lorbrena). This represents 0.8% of all adverse event reports for LORLATINIB.
43
Reports of Muscular weakness with LORLATINIB
0.8%
of all LORLATINIB reports
5
Deaths
22
Hospitalizations
How Dangerous Is Muscular weakness From LORLATINIB?
Of the 43 reports, 5 (11.6%) resulted in death, 22 (51.2%) required hospitalization.
Is Muscular weakness Listed in the Official Label?
Yes, Muscular weakness is listed as a known adverse reaction in the official FDA drug label for LORLATINIB.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which LORLATINIB Alternatives Have Lower Muscular weakness Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE